- Home
- AYTU vs YCBD Comparison
AYTU vs YCBD Comparison
Compare AYTU & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- YCBD
- Stock Information
- Founded
- AYTU N/A
- YCBD 2015
- Country
- AYTU United States
- YCBD United States
- Employees
- AYTU N/A
- YCBD N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- AYTU Health Care
- YCBD Health Care
- Exchange
- AYTU Nasdaq
- YCBD Nasdaq
- Market Cap
- AYTU 9.6M
- YCBD 7.8M
- IPO Year
- AYTU N/A
- YCBD N/A
- Fundamental
- Price
- AYTU $2.20
- YCBD $0.95
- Analyst Decision
- AYTU Strong Buy
- YCBD Strong Buy
- Analyst Count
- AYTU 2
- YCBD 1
- Target Price
- AYTU $10.00
- YCBD $3.00
- AVG Volume (30 Days)
- AYTU 207.1K
- YCBD 73.4K
- Earning Date
- AYTU 05-14-2025
- YCBD 08-13-2025
- Dividend Yield
- AYTU N/A
- YCBD N/A
- EPS Growth
- AYTU N/A
- YCBD N/A
- EPS
- AYTU N/A
- YCBD N/A
- Revenue
- AYTU $81,659,000.00
- YCBD $19,593,146.00
- Revenue This Year
- AYTU N/A
- YCBD $13.00
- Revenue Next Year
- AYTU $8.68
- YCBD $10.00
- P/E Ratio
- AYTU N/A
- YCBD N/A
- Revenue Growth
- AYTU 0.41
- YCBD N/A
- 52 Week Low
- AYTU $0.95
- YCBD $0.76
- 52 Week High
- AYTU $2.88
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- AYTU 62.85
- YCBD 49.80
- Support Level
- AYTU $2.04
- YCBD $0.85
- Resistance Level
- AYTU $2.45
- YCBD $1.00
- Average True Range (ATR)
- AYTU 0.13
- YCBD 0.08
- MACD
- AYTU 0.01
- YCBD 0.02
- Stochastic Oscillator
- AYTU 68.00
- YCBD 61.11
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.